Annexon outlines global registrational program for anx007 in geographic atrophy with fda alignment on vision preservation as primary endpoint

Alignment with fda on best corrected visual acuity ≥ 15-letter loss as primary outcome measure - representing the highest value outcome to patients and physicians
ANNX Ratings Summary
ANNX Quant Ranking